Katherine Leibowitz Presenting on Cyber Risk at MAGI Spring 2022 Clinical Research Hybrid Conference

Katherine Leibowitz will be co-presenting the “Cyberliability and Finding the Balance on Data Security” session at the upcoming MAGI Clinical Research Hybrid Conference.  Katherine’s co-presenters are Rebecca Rakoski of XPAN Law Partners and Bill Roberts of Day Pitney LLP.  The session’s three dynamic speakers will discuss why and how you should care about cyber risk in your clinical trial agreements and vendor contracts.

As technology and clinical trials continue to converge, the speakers will begin with a case study and overview of trending state laws followed by a deep dive into contract provisions, including sample language and what to watch out for

The hybrid in-person and virtual conference runs from May 1 – 4, 2022, in Boston, Massachusetts.  All presenters will attend in person.

Our Cyberliability session is on May 3rd from 10:45 a.m. – 12:30 p.m.  There will be Q&A to answer your questions directly.

Katherine will also be chairing the “Unanticipated Problems & Adverse Events” session and will moderate the Q&A.  The AE session is on May 2nd from 2:15 – 3 p.m.

All times are Eastern.

The MAGI conferences are a great way to learn about and stay up to date on clinical research – what is happening with sites, sponsors and CROs.  You can access the full program agenda for the MAGI Conference for Spring 2022 here.

This contents of this alert should not be construed as legal advice or a legal opinion on any specific facts or circumstances. This content is not intended to and does not, by its receipt, create an attorney-client relationship. The contents are intended for general informational purposes only. We urge you to consult your attorney about the specific situation and any legal questions you may have. Attorney advertising in some jurisdictions. © 2024 Leibowitz Law. All rights reserved. “Leibowitz Law” is a trade name of Leibowitz LLC.

Want to receive notifications?

To be notified when we post new Insights, please sign up for our email list. As industry thought leaders, Leibowitz Law Insights address developing issues at the intersection of law, regulation, technology and life sciences…


Lets talk about how we can help you.

Life sciences companies drive innovation.
Let us help you navigate this exciting journey ahead.